# Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine

> **NCT01094847** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 30 (estimated)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** DWJ1252

## Key facts

- **NCT ID:** NCT01094847
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01094847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01094847, "Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride Medicine". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01094847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*